Noah Holdings Reports Q2 2026 Results: Operating Margin Rises to 34.8%; Institutional Productivity Model Validated, AI-Powered Platform + Licensed Professionals + Ecosystem Partners Architecture Now Replicable
1H2026 operating margin reaches 36.3%, up 8.4 percentage points year-over-year; Q2 performance-based fees up 500.9% year-over-year SINGAPORE, Aug. 26, 2026 /PRNewswire/ -- Noah Holdings Limited ("Noah" or the "Company") (NYSE: NOAH; HKEX: 6686), a...
ImmunoForge Selected for the Ministry of SMEs and Startups' 'Global TIPS R&D' Program… "Expansion of the LMT Platform"
Development of Leptin receptor-based technology and hybrid LNP platform Combining Blood-Brain Barrier penetration and a one-month sustained-release formulation in a single structure, with potential applications in CNS-targeted therapeutics...
From the Lab to the Road: How Training Science Arrives in Brazil with the HUAWEI WATCH GT Runner 2
Two-time Olympic champion runs in Brazil with the smartwatch he helped create BRASILIA, Brazil, July 13, 2026 /PRNewswire/ -- For decades, elite racing relied on highly precise positioning and professional full-marathon modes — advantages strictly...
MOREH Demonstrates Production-Ready LLM Inference on Tenstorrent Galaxy, Achieving DGX A100-Class Performance with Improved Cost Efficiency
Reduces HBM Costs with GPU–Tenstorrent Heterogeneous Distributed Serving First unveiled at Tenstorrent's launch event, TT-Deploy, in San Francisco on May 1 SANTA CLARA, Calif., May 2, 2026 /PRNewswire/ -- Moreh, an AI infrastructure software...
BioDlink's Bevacizumab Approved for Market Launch in Nigeria, Accelerating Global Expansion
BioDlink's Bevacizumab Injection has been granted marketing authorization by Nigeria's National Agency for Food and Drug Administration and Control (NAFDAC), following GMP certifications in Brazil (a PIC/S member), Colombia, Egypt, Indonesia, and...